<DOC>
	<DOCNO>NCT01262547</DOCNO>
	<brief_summary>This study evaluate micrografting use harvest graft process design Momelan Technologies . The overall concept harvest several small piece skin , measure 1.75 mm diameter normal pigmented area use commercially available suction blister device , adhere sterile elastomeric substrate place recipient area prepare epidermal dermabrasion ( removal epidermis ) .</brief_summary>
	<brief_title>A New Micrografting Technique Vitiligo</brief_title>
	<detailed_description>Participants vitiligo patch undergo removal epidermis affect vitiligo skin dermabrasion . Several small piece pigment skin ( 1.75mm ) patient take another area use suction blister device . The harvested pigmented skin adhere sterile elastomeric substrate place previously dermabraded affected area . Originally primary outcome percentage change pigmentation UV photos 10 week sit undergoing graft compare control sit . However , unable take UV photo , revise primary outcome .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<criteria>Be 18 80 year old Have diagnosis stable vitiligo define Vitiligo Disease Activity Score 0 1 Has 3 comparable vitiliginous area trunk extremity ( exclude hand ) measure least 3cm√ó3cm size , least 80 % depigmentation , anticipate equal sun exposure . Have use topical therapy patch Ultraviolet light therapy least 2 week ( subject may restart phototherapy week 10 desire ) Be able understand requirement study , risk involve , able sign inform consent form Agree follow undergo studyrelated procedure Female patient breastfeed , pregnant , plan become pregnant Patients history hypertrophic scar keloid psoriasis Subjects dose coumadin , warfarin , Plavix least 325 mg aspirin . Concurrent use immunosuppressive medication oral steroid , tacrolimus cytotoxic reagent within 2 week graft ) Subject receive topical therapy UV light ( phototherapy ) last 2 week Patients positive HIV status Patients withDiabetes Mellitus hemoglobin A1C 8 . Subjects dermatologic condition may Koebnerize psoriasis lichen planus . Participation another interventional study potential exposure investigational drug within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>